List of Tables
Table 1. Human Coagulation Factor Ⅷ Market Trends
Table 2. Human Coagulation Factor Ⅷ Market Drivers & Opportunity
Table 3. Human Coagulation Factor Ⅷ Market Challenges
Table 4. Human Coagulation Factor Ⅷ Market Restraints
Table 5. Global Human Coagulation Factor Ⅷ Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Human Coagulation Factor Ⅷ Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Human Coagulation Factor Ⅷ Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Human Coagulation Factor Ⅷ Product Type
Table 9. Key Companies Time to Begin Mass Production of Human Coagulation Factor Ⅷ
Table 10. Global Human Coagulation Factor Ⅷ Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor Ⅷ as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Human Coagulation Factor Ⅷ Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Human Coagulation Factor Ⅷ Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Human Coagulation Factor Ⅷ Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Human Coagulation Factor Ⅷ Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Human Coagulation Factor Ⅷ Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Human Coagulation Factor Ⅷ Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Human Coagulation Factor Ⅷ Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Human Coagulation Factor Ⅷ Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Human Coagulation Factor Ⅷ Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Human Coagulation Factor Ⅷ Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Human Coagulation Factor Ⅷ Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Human Coagulation Factor Ⅷ Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Human Coagulation Factor Ⅷ Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Human Coagulation Factor Ⅷ Sales Value by Region (2019-2024) & (%)
Table 27. Global Human Coagulation Factor Ⅷ Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Human Coagulation Factor Ⅷ Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Human Coagulation Factor Ⅷ Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Human Coagulation Factor Ⅷ Sales Value, (2025-2030) & (US$ Million)
Table 31. Bayer Basic Information List
Table 32. Bayer Description and Business Overview
Table 33. Bayer Human Coagulation Factor Ⅷ Products, Services and Solutions
Table 34. Revenue (US$ Million) in Human Coagulation Factor Ⅷ Business of Bayer (2019-2024)
Table 35. Bayer Recent Developments
Table 36. CSL Behring Basic Information List
Table 37. CSL Behring Description and Business Overview
Table 38. CSL Behring Human Coagulation Factor Ⅷ Products, Services and Solutions
Table 39. Revenue (US$ Million) in Human Coagulation Factor Ⅷ Business of CSL Behring (2019-2024)
Table 40. CSL Behring Recent Developments
Table 41. Baxter Basic Information List
Table 42. Baxter Description and Business Overview
Table 43. Baxter Human Coagulation Factor Ⅷ Products, Services and Solutions
Table 44. Revenue (US$ Million) in Human Coagulation Factor Ⅷ Business of Baxter (2019-2024)
Table 45. Baxter Recent Developments
Table 46. Grifols Basic Information List
Table 47. Grifols Description and Business Overview
Table 48. Grifols Human Coagulation Factor Ⅷ Products, Services and Solutions
Table 49. Revenue (US$ Million) in Human Coagulation Factor Ⅷ Business of Grifols (2019-2024)
Table 50. Grifols Recent Developments
Table 51. Octapharma Basic Information List
Table 52. Octapharma Description and Business Overview
Table 53. Octapharma Human Coagulation Factor Ⅷ Products, Services and Solutions
Table 54. Revenue (US$ Million) in Human Coagulation Factor Ⅷ Business of Octapharma (2019-2024)
Table 55. Octapharma Recent Developments
Table 56. Pfizer Basic Information List
Table 57. Pfizer Description and Business Overview
Table 58. Pfizer Human Coagulation Factor Ⅷ Products, Services and Solutions
Table 59. Revenue (US$ Million) in Human Coagulation Factor Ⅷ Business of Pfizer (2019-2024)
Table 60. Pfizer Recent Developments
Table 61. Taibang Bio Basic Information List
Table 62. Taibang Bio Description and Business Overview
Table 63. Taibang Bio Human Coagulation Factor Ⅷ Products, Services and Solutions
Table 64. Revenue (US$ Million) in Human Coagulation Factor Ⅷ Business of Taibang Bio (2019-2024)
Table 65. Taibang Bio Recent Developments
Table 66. Shanghai Laishi Basic Information List
Table 67. Shanghai Laishi Description and Business Overview
Table 68. Shanghai Laishi Human Coagulation Factor Ⅷ Products, Services and Solutions
Table 69. Revenue (US$ Million) in Human Coagulation Factor Ⅷ Business of Shanghai Laishi (2019-2024)
Table 70. Shanghai Laishi Recent Developments
Table 71. Hualan Bio Basic Information List
Table 72. Hualan Bio Description and Business Overview
Table 73. Hualan Bio Human Coagulation Factor Ⅷ Products, Services and Solutions
Table 74. Revenue (US$ Million) in Human Coagulation Factor Ⅷ Business of Hualan Bio (2019-2024)
Table 75. Hualan Bio Recent Developments
Table 76. Guangdong Shuanglin Basic Information List
Table 77. Guangdong Shuanglin Description and Business Overview
Table 78. Guangdong Shuanglin Human Coagulation Factor Ⅷ Products, Services and Solutions
Table 79. Revenue (US$ Million) in Human Coagulation Factor Ⅷ Business of Guangdong Shuanglin (2019-2024)
Table 80. Guangdong Shuanglin Recent Developments
Table 81. GreenCross Basic Information List
Table 82. GreenCross Description and Business Overview
Table 83. GreenCross Human Coagulation Factor Ⅷ Products, Services and Solutions
Table 84. Revenue (US$ Million) in Human Coagulation Factor Ⅷ Business of GreenCross (2019-2024)
Table 85. GreenCross Recent Developments
Table 86. Pfizer Basic Information List
Table 87. Pfizer Description and Business Overview
Table 88. Pfizer Human Coagulation Factor Ⅷ Products, Services and Solutions
Table 89. Revenue (US$ Million) in Human Coagulation Factor Ⅷ Business of Pfizer (2019-2024)
Table 90. Pfizer Recent Developments
Table 91. Key Raw Materials Lists
Table 92. Raw Materials Key Suppliers Lists
Table 93. Human Coagulation Factor Ⅷ Downstream Customers
Table 94. Human Coagulation Factor Ⅷ Distributors List
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Human Coagulation Factor Ⅷ Product Picture
Figure 2. Global Human Coagulation Factor Ⅷ Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Human Coagulation Factor Ⅷ Sales Value (2019-2030) & (US$ Million)
Figure 4. Human Coagulation Factor Ⅷ Report Years Considered
Figure 5. Global Human Coagulation Factor Ⅷ Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Coagulation Factor Ⅷ Revenue in 2023
Figure 7. Human Coagulation Factor Ⅷ Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Recombinant Factor VIII Picture
Figure 9. Human Factor VIII Picture
Figure 10. Global Human Coagulation Factor Ⅷ Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Human Coagulation Factor Ⅷ Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Hemophilia A
Figure 13. Product Picture of Relvent Bleeding Diseases
Figure 14. Global Human Coagulation Factor Ⅷ Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Human Coagulation Factor Ⅷ Sales Value Market Share by Application, 2023 & 2030
Figure 16. North America Human Coagulation Factor Ⅷ Sales Value (2019-2030) & (US$ Million)
Figure 17. North America Human Coagulation Factor Ⅷ Sales Value by Country (%), 2023 VS 2030
Figure 18. Europe Human Coagulation Factor Ⅷ Sales Value (2019-2030) & (US$ Million)
Figure 19. Europe Human Coagulation Factor Ⅷ Sales Value by Country (%), 2023 VS 2030
Figure 20. Asia Pacific Human Coagulation Factor Ⅷ Sales Value (2019-2030) & (US$ Million)
Figure 21. Asia Pacific Human Coagulation Factor Ⅷ Sales Value by Country (%), 2023 VS 2030
Figure 22. South America Human Coagulation Factor Ⅷ Sales Value (2019-2030) & (US$ Million)
Figure 23. South America Human Coagulation Factor Ⅷ Sales Value by Country (%), 2023 VS 2030
Figure 24. Middle East & Africa Human Coagulation Factor Ⅷ Sales Value (2019-2030) & (US$ Million)
Figure 25. Middle East & Africa Human Coagulation Factor Ⅷ Sales Value by Country (%), 2023 VS 2030
Figure 26. Key Countries/Regions Human Coagulation Factor Ⅷ Sales Value (%), (2019-2030)
Figure 27. United States Human Coagulation Factor Ⅷ Sales Value, (2019-2030) & (US$ Million)
Figure 28. United States Human Coagulation Factor Ⅷ Sales Value by Type (%), 2023 VS 2030
Figure 29. United States Human Coagulation Factor Ⅷ Sales Value by Application (%), 2023 VS 2030
Figure 30. Europe Human Coagulation Factor Ⅷ Sales Value, (2019-2030) & (US$ Million)
Figure 31. Europe Human Coagulation Factor Ⅷ Sales Value by Type (%), 2023 VS 2030
Figure 32. Europe Human Coagulation Factor Ⅷ Sales Value by Application (%), 2023 VS 2030
Figure 33. China Human Coagulation Factor Ⅷ Sales Value, (2019-2030) & (US$ Million)
Figure 34. China Human Coagulation Factor Ⅷ Sales Value by Type (%), 2023 VS 2030
Figure 35. China Human Coagulation Factor Ⅷ Sales Value by Application (%), 2023 VS 2030
Figure 36. Japan Human Coagulation Factor Ⅷ Sales Value, (2019-2030) & (US$ Million)
Figure 37. Japan Human Coagulation Factor Ⅷ Sales Value by Type (%), 2023 VS 2030
Figure 38. Japan Human Coagulation Factor Ⅷ Sales Value by Application (%), 2023 VS 2030
Figure 39. South Korea Human Coagulation Factor Ⅷ Sales Value, (2019-2030) & (US$ Million)
Figure 40. South Korea Human Coagulation Factor Ⅷ Sales Value by Type (%), 2023 VS 2030
Figure 41. South Korea Human Coagulation Factor Ⅷ Sales Value by Application (%), 2023 VS 2030
Figure 42. Southeast Asia Human Coagulation Factor Ⅷ Sales Value, (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Human Coagulation Factor Ⅷ Sales Value by Type (%), 2023 VS 2030
Figure 44. Southeast Asia Human Coagulation Factor Ⅷ Sales Value by Application (%), 2023 VS 2030
Figure 45. India Human Coagulation Factor Ⅷ Sales Value, (2019-2030) & (US$ Million)
Figure 46. India Human Coagulation Factor Ⅷ Sales Value by Type (%), 2023 VS 2030
Figure 47. India Human Coagulation Factor Ⅷ Sales Value by Application (%), 2023 VS 2030
Figure 48. Human Coagulation Factor Ⅷ Industrial Chain
Figure 49. Human Coagulation Factor Ⅷ Manufacturing Cost Structure
Figure 50. Channels of Distribution (Direct Sales, and Distribution)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
